Applications of Nanotechnology in Drug Delivery Systems
DOI:
https://doi.org/10.47419/bjbabs.v5i3.295Keywords:
Nanotechnology, drug delivery, nanoparticles, healthcareAbstract
Nanotechnology offers a revolutionary approach to drug delivery systems, with nanoparticles playing a central role. These particles, typically sized between 1 and 100 nanometers, possess unique properties that enhance medication effectiveness and reduce side effects. This article explores the key applications of nanotechnology in drug delivery. The ability to deliver drugs directly to target sites is a significant advantage. Nanoparticles can be engineered to navigate biological barriers and reach specific cells or tissues, minimizing damage to healthy areas. This targeted approach is particularly valuable in cancer treatment, where it can significantly reduce the cytotoxicity of chemotherapeutic drugs. Nanotechnology improves the solubility and bioavailability of poorly soluble drugs. By encapsulating drugs within nanoparticles, their absorption and therapeutic effect are significantly enhanced.
Downloads
References
Picraux ST; 2025.
Samuel HS, Ekpan FM. Revolutionizing Drugs Administration: Techniques in Drug Delivery and Development. Int J Biochem Physiol. 2023;8(2):1–15. 10.23880/ijbp- 16000238. DOI: https://doi.org/10.23880/ijbp-16000238
Farokhzad OC, Langer R. Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev. 2006;58(14):1456–1459. 10.1016/j.addr.2006.09.011. DOI: https://doi.org/10.1016/j.addr.2006.09.011
Ori MO, Ekpan FDM, Samuel HS, Egwuatu OP. Integration of Artificial Intelligence in Nanomedicine. Eurasian J Sci Tech. 2024;4(2):88 –104. 10.48309/ejst.2024.422419.1105.
Filipponi L, Nicolau DV. Cell Patterning. John Wiley & Sons; 2006. 10.1002/9780471740360.ebs1350. DOI: https://doi.org/10.1002/9780471740360.ebs1350
Egwuatu OP, Ori MO, Samuel HS, Ekpan FM. AI-enabled Diagnostics and Monitoring in Nanomedicine. Eurasian Journal of Science and Technology. 2024;4(3):208– 229. 10.48309/ejst.2024.426725.1116.
Lombardo D, Kiselev MA, Caccamo MT. Smart Nanoparticles for Drug Delivery Application: Development of Versatile Nanocarrier Platforms in Biotechnology and Nanomedicine. J Nanomater. 2019;2019(1):1–26. 10.1155/2019/3702518. DOI: https://doi.org/10.1155/2019/3702518
Ekpan FDM, Ori MO, Samuel HS, Ekpan FM. The Synergy of AI and Drug Deliv- ery: A Revolution in Healthcare. International Journal of Advanced Biological and Biomedical Research. 2024;12(1):44–66. 10.48309/ijabbr.2024.2014408.1467.
Zhao Y, Bai C, Brinker CJ, Chi L, Dawson KA, Gogotsi Y, et al. Nano as a Rosetta Stone: The Global Roles and Opportunities for Nanoscience and Nanotechnology. ACS Nano. 2019;13(10):10853–10855. 10.1021/acsnano.9b08042. DOI: https://doi.org/10.1021/acsnano.9b08042
Gul-Uludağ H, Valencia-Serna J, Kucharski C, Curtis LAM, Jiang X, Lar- ratt L, et al. Polymeric nanoparticle-mediated silencing of CD44 receptor in CD34+ acute myeloid leukemia cells. Leuk Res . 2014;38(11):1299–1308. 10.1016/j.leukres.2014.08.008. DOI: https://doi.org/10.1016/j.leukres.2014.08.008
Yusuf A, Almotairy ARZ, Henidi H, Alshehri OY, Aldughaim MS. Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles’ Physicochem- ical Properties on Responses in Biological Systems. Polymers. 2023;15(7):1596–1596. 10.3390/polym15071596. DOI: https://doi.org/10.3390/polym15071596
Gavas S, Quazi S, Karpiński TM. Nanoparticles for Cancer Therapy: Cur- rent Progress and Challenges. Nanoscale research letters. 2021;16(173):1–21. 10.1186/s11671-021-03628-6. DOI: https://doi.org/10.1186/s11671-021-03628-6
Dadwal A, Baldi A, Narang RK. Nanoparticles as carriers for drug deliv- ery in cancer. Artif Cells Nanomed Biotechnol. 2018;46(2):295–305. 10.1080/21691401.2018.1457039. DOI: https://doi.org/10.1080/21691401.2018.1457039
Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y, et al. Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Frontiers in molecular biosciences. 2020;7. 10.3389/fmolb.2020.00193. DOI: https://doi.org/10.3389/fmolb.2020.00193
Sikora T, Morawska K, Lisowski W, Rytel P, Dylong A. Application of Optical Meth- ods for Determination of Concentration of Doxorubicin in Blood and Plasma. Pharmaceutics. 2022;15(2):112–112. 10.3390/ph15020112. DOI: https://doi.org/10.3390/ph15020112
Yamada S, Shanbhag S, Mustafa K. Scaffolds in Periodontal Regenerative Treatment. Dent Clin North Am . 2022;66(1):111–130. 10.1016/j.cden.2021.06.004. DOI: https://doi.org/10.1016/j.cden.2021.06.004
Montaseri H, Kruger CA, Abrahamse H. Inorganic Nanoparticles Applied for Active Targeted Photodynamic Therapy of Breast Cancer. Pharmaceutics. 2021;13(3):296– 296. 10.3390/pharmaceutics13030296. DOI: https://doi.org/10.3390/pharmaceutics13030296
Reis DR, Zin G, Senna EL, Ambrosi A, Luccio MD. A modified premix method for the emulsification of spearmint essential oil (Mentha spicata) by ceramic membranes. Surfaces and Interfaces. 2021;26. 10.1016/j.surfin.2021.101328. DOI: https://doi.org/10.1016/j.surfin.2021.101328
Bustamante-Torres M, Pino-Ramos VH, Romero-Fierro D, Hidalgo-Bonilla SP, Magaña H, Bucio E. Synthesis and Antimicrobial Properties of Highly Cross-Linked pH-Sensitive Hydrogels through Gamma Radiation. Polymers. 2021;13(14):2223– 2223. 10.3390/polym13142223. DOI: https://doi.org/10.3390/polym13142223
Alaei S, Ghasemian E, Vatanara A. Spray drying of cefixime nanosuspension to form stabilized and fast dissolving powder. Powder Technology. 2016;288:241–248. 10.1016/j.powtec.2015.10.051. DOI: https://doi.org/10.1016/j.powtec.2015.10.051
Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, et al. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Phar- macol . 2010;79(3):330–338. 10.1016/j.bcp.2009.09.003. DOI: https://doi.org/10.1016/j.bcp.2009.09.003
Sharma S, Sudhakara P, Singh J, Ilyas RA, Asyraf MRM, Razman MR. Criti- cal Review of Biodegradable and Bioactive Polymer Composites for Bone Tissue Engineering and Drug Delivery Applications. Polymers. 2021;13(16):2623–2623. 10.3390/polym13162623. DOI: https://doi.org/10.3390/polym13162623
Rizwan K, Rasheed T, Bilal M. 10 - Nano-biodegradation of polymers. Biodegrada- tion and Biodeterioration At the Nanoscale. 2022;p. 213–238. 10.1016/B978-0-12- 823970-4.00010-5. DOI: https://doi.org/10.1016/B978-0-12-823970-4.00010-5
Subbaiah MAM, Meanwell NA. Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design. Journal of Medicinal Chem- istry. 2021;64(19):14046–14128. 10.1021/acs.jmedchem.1c01215. DOI: https://doi.org/10.1021/acs.jmedchem.1c01215
Lin B, Weiwei L, Chen Z, Zhang Y, Duan Y, Lu X, et al. Enhancing the Poten- tial of Miniature-Scale DNA-Compatible Radical Reactions via an Electron Donor– Acceptor Complex and a Reversible Adsorption to Solid Support Strategy. Organic Letters. 2021;23(19):7381–7385. 10.1021/acs.orglett.1c02562. DOI: https://doi.org/10.1021/acs.orglett.1c02562
Kosmidou T. Structural, mechanical and electrical characterization of epoxy- amine/carbon black nanonocomposites. Express Polym Lett. 2008;2(5):364–372. 10.3144/expresspolymlett.2008.43. DOI: https://doi.org/10.3144/expresspolymlett.2008.43
Gacitua W, Ballerini A, Zhang J. Polymer nanocomposites: synthetic and natural fillers a review. Maderas Cienc y Tecnol. 2005;7(3):159–178. DOI: https://doi.org/10.4067/S0718-221X2005000300002
Dan N, Setua S, Kashyap VK, Khan S, Jaggi M, Yallapu MM, et al. Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications. Pharmaceuti- cals (Basel) . 2018;11(2):32–32. 10.3390/ph11020032. DOI: https://doi.org/10.3390/ph11020032
Polakis P. Antibody Drug Conjugates for Cancer Therapy. Pharmacol Rev. 2016;68(1):3–19. 10.1124/pr.114.009373. DOI: https://doi.org/10.1124/pr.114.009373
Kumar R, Chalarca CFS, Bockman MR, Bruggen CV, Grimme CJ, Dalal RJ, et al. Polymeric Delivery of Therapeutic Nucleic Acids. Chemical Reviews. 2016;121:11527–11652. 10.1021/acs.chemrev.0c00997. DOI: https://doi.org/10.1021/acs.chemrev.0c00997
Chen G, Katrekar D, Mali P. RNA-Guided Adenosine Deaminases: Advances and Challenges for Therapeutic RNA Editing. Biochemistry. 2019;58(15):1947–1957. 10.1021/acs.biochem.9b00046. DOI: https://doi.org/10.1021/acs.biochem.9b00046
Brightman MW. Morphology of blood-brain interfaces. Exp Eye Res. 1977;25(1):1– 25. 10.1016/S0014-4835(77)80008-0. DOI: https://doi.org/10.1016/S0014-4835(77)80008-0
Misra A, Ganesh S, Shahiwala A, Shah SP. Drug delivery to the central nervous system: a review. J Pharm Pharmaceut Sci. 2003;6:252–273. 12935438.
Amić A, Marković Z, Klein E, Marković JMD, Milenković D. Theoretical study of the thermodynamics of the mechanisms underlying antiradical activity of cinnamic acid derivatives. Food Chem. 2018;246:481–489. 10.1016/j.foodchem.2017.11.100. DOI: https://doi.org/10.1016/j.foodchem.2017.11.100
Vauthier C, Labarre D, Ponchel G. Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery. J Drug Target. 2007;15(10):641–663. 10.1080/10611860701603372. DOI: https://doi.org/10.1080/10611860701603372
Veselov VV, Nosyrev AE, Jicsinszky L, Alyautdin RN, Cravotto G. Targeted Delivery Methods for Anticancer Drugs. Cancers. 2022;14(3):622–622. 10.3390/cancers14030622. DOI: https://doi.org/10.3390/cancers14030622
Glasgow MD, Chougule MB. Recent Developments in Active Tumor Targeted Multi-functional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging. J Biomed Nanotechnol. 2015;11(11):1859–1898. 10.1166/jbn.2015.2145. DOI: https://doi.org/10.1166/jbn.2015.2145
Jianmin L, Qingluo W, Xia NG, Adilijiang Y, Li Z, Hou Z, et al. Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy. Pharmaceutics. 2023;15(9):2233–2233. 10.3390/pharmaceutics15092233. DOI: https://doi.org/10.3390/pharmaceutics15092233
Attia MF, Anton N, Wallyn J, Omran Z, Vandamme T. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J Pharm Pharmacol. 2019;71(8):1185–1198. 10.1111/jphp.13098. DOI: https://doi.org/10.1111/jphp.13098
Klibanov AL, Maruyama K, Torchilin VP, Huang L. Amphipathic polyethyleneg- lycols effectively prolong the circulation time of liposomes. FEBS Lett. 1997;268(1):235–237. 10.1016/0014-5793(90)81016-h. DOI: https://doi.org/10.1016/0014-5793(90)81016-H
Fang J, Nakamura H, Maeda H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63(3):136–151. 10.1016/j.addr.2010.04.009. DOI: https://doi.org/10.1016/j.addr.2010.04.009
Zou TB, He TP, Li HB, Tang HW, Xia EQ. The Structure-Activity Relationship of the Antioxidant Peptides from Natural Proteins. Molecules . 2016;21(1):72–72. 10.3390/molecules21010072. DOI: https://doi.org/10.3390/molecules21010072
Torchilin VP. Micellar Nanocarriers: Pharmaceutical Perspectives. Pharm Res. 2006;24:1–16. 10.1007/s11095-006-9132-0. DOI: https://doi.org/10.1007/s11095-006-9132-0
Rad AH, Asiaee F, Jafari S, Shayanfar A, Lavasanifar A, Molavi O, et al. Poly(ethylene glycol)-poly(ε-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin. Bioimpacts. 2019;10(2):87–95. 10.34172/bi.2020.11. DOI: https://doi.org/10.34172/bi.2020.11
Biswas S, Kumari P, Lakhani PM, Ghosh B. Recent advances in polymeric micelles for anti-cancer drug delivery. Eur J Pharm Sci . 2016;83:184–202. 10.1016/j.ejps.2015.12.031. DOI: https://doi.org/10.1016/j.ejps.2015.12.031
Kwon G, Suwa S, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly (ethy- lene oxide-aspartate) block copolymer-adriamycin conjugates. J Control Release. 1994;29(1-2):17–23. 10.1016/0168-3659(94)90118-X. DOI: https://doi.org/10.1016/0168-3659(94)90118-X
Gillies ER, Fréchet JMJ. Dendrimers and dendritic polymers in drug delivery. Drug Discov Today. 2005;10(1):35–43. 10.1016/S1359-6446(04)03276-3. DOI: https://doi.org/10.1016/S1359-6446(04)03276-3
She W, Pan D, Luo K, He B, Cheng G, Zhang C, et al. PEGylated dendrimer-doxorubicin cojugates as pH-sensitive drug delivery systems: Synthe- sis and in vitro characterization. J Biomed Nanotechnol. 2015;11(6):964–978. 10.1166/jbn.2015.1865. DOI: https://doi.org/10.1166/jbn.2015.1865
Singh V, Sahebkar A, Kesharwani P. Poly (propylene imine) dendrimer as an emerg- ing polymeric nanocarrier for anticancer drug and gene delivery. Eur Polym J. 2021;158:110683–110683. 10.1016/j.eurpolymj.2021.110683. DOI: https://doi.org/10.1016/j.eurpolymj.2021.110683
Chen L, Li J, Fan Y, Qiu J, Cao L, Laurent R, et al. Revisiting Cationic Phosphorus Dendrimers as a Nonviral Vector for Optimized Gene Delivery Toward Cancer Therapy Applications. Biomacromolecules. 2021;21(6):2502–2511. 10.1021/acs.biomac.0c00458. DOI: https://doi.org/10.1021/acs.biomac.0c00458
Hardenia A, Maheshwari N, Hardenia SS, Dwivedi SK, Maheshwari R, Tekade RK. Chapter 1 - Scientific Rationale for Designing Controlled Drug Delivery Systems. Basic Fundamentals of Drug Delivery. 2019;p. 1–28. 10.1016/B978-0-12-817909- 3.00001-7. DOI: https://doi.org/10.1016/B978-0-12-817909-3.00001-7
Benoit DS, Overby CT, Sims KR, Jr, Ackun-Farmmer MA. Drug delivery systems. Biomaterials Science. 2019;p. 1237–1266. DOI: https://doi.org/10.1016/B978-0-12-816137-1.00078-7
Shah A, Aftab S, Nisar J, Ashiq MN, Iftikhar FJ. Nanocarriers for Tar- geted drug delivery. J Drug Delivery Sci Technol. 2021;62:102426–102426. 10.1016/j.jddst.2021.102426. DOI: https://doi.org/10.1016/j.jddst.2021.102426
Saleem MA, Siddique MY, Zubair M, Ashfaq M, Nazar MF. Chapter 11 - Self- nanoemulsifying drug delivery systems with bioavailability potential. Novel Plat- forms for Drug Delivery Applications. 2023;p. 257–275. 10.1016/B978-0-323-91376- 8.00001-X. DOI: https://doi.org/10.1016/B978-0-323-91376-8.00001-X
Naz F, Siddique YH. Nanotechnology: Its Application in Treating Neurode- generative Diseases. CNS Neurol Discord Drug Targets. 2021;20(1):34–53. 10.2174/1871527319666200916121515. DOI: https://doi.org/10.2174/1871527319666200916121515
Wang T, Rong F, Tang Y, Li M, Feng T, Zhou Q, et al. Targeted polymer-based antibiotic delivery system: A promising option for treating bacterial infections via macromolecular approaches. Progress in Polymer Science. 2021;116:101389– DOI: https://doi.org/10.1016/j.progpolymsci.2021.101389
10.1016/j.progpolymsci.2021.101389. DOI: https://doi.org/10.1016/j.progpolymsci.2021.101389
Xue Y, Gao Y, Meng F, Luo L. Recent progress of nanotechnology-based theranostic systems in cancer treatments. Cancer Biology and Medicine. 2021;18(2):336–351. 10.20892/j.issn.2095-3941.2020.0510. DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0510
Lyu Y, Fang Y, Miao Q, Zhen X, Ding D, Pu K. Intraparticle Molecular Orbital Engineering of Semiconducting Polymer Nanoparticles as Amplified Theranos- tics for in Vivo Photoacoustic Imaging and Photothermal Therapy. ACS Nano. 2016;10(4):4472–4481. 10.1021/acsnano.6b00168. DOI: https://doi.org/10.1021/acsnano.6b00168
Janib SM, Moses AS, Mackay JA. Imaging and drug delivery using therapeutic nanoparticles. Advanced drug delivery reviews. 2010;62(11):1052–1063. 10.1016/j.addr.2010.08.004. DOI: https://doi.org/10.1016/j.addr.2010.08.004
Jokerst JV, Gambhir SS. Molecular imaging with theranostic nanoparticles. Accounts of chemical research. 2011;44(10):1050–1060. 10.1021/ar200106e. DOI: https://doi.org/10.1021/ar200106e
Chen F, Ehlerding EB, Cai W. Theranostic Nanoparticles. Journal of Nuclear Medicine. 2014;55(12):1919–1922. 10.2967/jnumed.114.146019. DOI: https://doi.org/10.2967/jnumed.114.146019
Kelkar SS, Reineke TM. Theranostics: Combining Imaging and Therapy. Bioconju- gate Chemistry. 2011;22(10):1879–1903. 10.1021/bc200151q. DOI: https://doi.org/10.1021/bc200151q
Tang M, Ji X, Xu H, Zhang L, Jiang A, Song B, et al. Photostable and Biocom- patible Fluorescent Silicon Nanoparticles-Based Theranostic Probes for Simultane- ous Imaging and Treatment of Ocular Neovascularization. Analytical chemistry. 2018;90(13):8188–8195. 10.1021/acs.analchem.8b01580. DOI: https://doi.org/10.1021/acs.analchem.8b01580
Luong D, Sau S, Kesharwani P, Iyer AK. Polyvalent folate-dendrimer-coated iron oxide theranostic nanoparticles for simultaneous magnetic resonance imag- ing and precise cancer cell targeting. Biomacromolecules. 2017;18(4):1197–1209. 10.1021/acs.biomac.6b01885. DOI: https://doi.org/10.1021/acs.biomac.6b01885
Li Y, Wu Y, Chen J, Wan J, Xiao C, Guan J, et al. A simple glutathione- responsive turn-on theranostic nanoparticle for dual-modal imaging and chemo-photothermal combination therapy. Nano Letters. 2019;19(8):5806–5817. 10.1021/acs.nanolett.9b02769. DOI: https://doi.org/10.1021/acs.nanolett.9b02769
Vandghanooni S, Barar J, Eskandani M, Omidi Y. Aptamer-conjugated mesoporous silica nanoparticles for simultaneous imaging and therapy of cancer. TrAC Trends in Analytical Chemistry. 2020;123:115759–115759. 10.1016/j.trac.2019.115759. DOI: https://doi.org/10.1016/j.trac.2019.115759
Sharma G, Kondelaji HR, Joshi A. X-ray and mr contrast bearing nanoparticles enhance the therapeutic response of image-guided radiation therapy for oral cancer. Technology in Cancer Research & Treatment. 2023;22. 10.1177/15330338231189. DOI: https://doi.org/10.1177/15330338231189593
Li X, Wang X, Zhao C, Shao L, Lu J, Tong Y, et al. From one to all: self-assembled theranostic nanoparticles for tumor-targeted imaging and programmed photoactive therapy. Journal of Nanobiotechnology. 2019;17(23):17–17. 10.1186/s12951-019- 0450-x. DOI: https://doi.org/10.1186/s12951-019-0450-x
Singh D, Dilnawaz F, Sahoo SK. Challenges of moving theranostic nanomedicine into the clinic. Nanomedicine. 2020;15(2):111–114. 10.2217/nnm-2019-0401. DOI: https://doi.org/10.2217/nnm-2019-0401
Kim TH, Lee S, Chen X. Nanotheranostics for personalized medicine. Expert Review of Molecular Diagnostics. 2013;13(3):257–269. 10.1586/erm.13.15. DOI: https://doi.org/10.1586/erm.13.15
Esmaeilpour D, Broscheit JA, Shityakov S. Cyclodextrin-based polymeric material bound to corona protein for theranostic applications. International Journal of Molecular Sciences. 2022;23(21):13505–13505. 10.3390/ijms232113505. DOI: https://doi.org/10.3390/ijms232113505
Feng G, Liu B. Aggregation-Induced Emission (AIE) Dots: Emerging Theragnostic Nanolights. Accounts of Chemical Research. 2018;51(6):1404–1414. 10.1021/acs.accounts.8b00060. DOI: https://doi.org/10.1021/acs.accounts.8b00060
Kang M, Zhang Z, Song N, Li M, Sun P, Chen X, et al. Aggregation-enhanced theranostics: AIE sparkles in the biomedical field. Aggregate. 2020;1(1):80–106. 10.1002/agt2.7. DOI: https://doi.org/10.1002/agt2.7
Vats S, Singh M, Siraj S, Singh H, Tandon S. Role of nanotechnology in theranostics and personalized medicines. Journal of Health Research and Reviews. 2017;4(1):1–7. 10.4103/2394-2010.199328. DOI: https://doi.org/10.4103/2394-2010.199328
Li L, Lu Y, Jiang C, Zhu Y, Yang X, Hu X, et al. Actively targeted deep tissue imaging and photothermal-chemo therapy of breast cancer by antibody-functionalized drug-loaded x-ray-responsive bismuth sulfide@mesoporous silica core-shell nanoparticles. Advanced Functional Materials. 2018;28(5):28–28. 10.1002/adfm.201704623. DOI: https://doi.org/10.1002/adfm.201704623
Wang Y, Sun S, Zhang Z, Shi D. Nanomaterials for Cancer Precision Medicine. Advanced Materials. 2018;30(17):1705660–1705660. 10.1002/adma.201705660. DOI: https://doi.org/10.1002/adma.201705660
Additional Files
Published
Issue
Section
Categories
License
Copyright (c) 2024 Humphrey Samuel, Gideon Okibe, Manasseh Ilumunter, Undie David, Esther Omeche, Fatima Mahmud
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain all proprietary rights, including copyright, such as patent and trademark rights and rights to any process or procedure described in the article.
